Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Beta Urogastrone
2. Beta-urogastrone
3. Egf
4. Epidermal Growth Factor-urogastrone
5. Growth Factor, Epidermal
6. Growth Factor-urogastrone, Epidermal
7. Human Urinary Gastric Inhibitor
8. Urogastrone
1. 62229-50-9
2. Gastrone, Uro-
3. Uroanthelone
4. Uroenterone
5. Urogastron
6. Urogastrone
7. Kutrol
8. Beta-urogastrone
9. Anthelone U
10. Urogastrone [jan]
11. Gastrone, Gamma-uro-
12. Gastrone, Beta-uro- (human)
13. Epidermal Growth Factor (egf)
14. Ccris 7234
15. Einecs 263-468-7
16. Epidermal Growth Factor-urogastrone
Molecular Weight | 6046 g/mol |
---|---|
Molecular Formula | C257H381N73O83S7 |
XLogP3 | -19.6 |
Hydrogen Bond Donor Count | 96 |
Hydrogen Bond Acceptor Count | 96 |
Rotatable Bond Count | 193 |
Exact Mass | 6043.5948607 g/mol |
Monoisotopic Mass | 6041.5881511 g/mol |
Topological Polar Surface Area | 2560 Ų |
Heavy Atom Count | 420 |
Formal Charge | 0 |
Complexity | 15400 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 51 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
15
PharmaCompass offers a list of Human Epidermal Growth Factor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Human Epidermal Growth Factor manufacturer or Human Epidermal Growth Factor supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Human Epidermal Growth Factor manufacturer or Human Epidermal Growth Factor supplier.
PharmaCompass also assists you with knowing the Human Epidermal Growth Factor API Price utilized in the formulation of products. Human Epidermal Growth Factor API Price is not always fixed or binding as the Human Epidermal Growth Factor Price is obtained through a variety of data sources. The Human Epidermal Growth Factor Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Epidermal Growth Factor-Urogastrone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Epidermal Growth Factor-Urogastrone, including repackagers and relabelers. The FDA regulates Epidermal Growth Factor-Urogastrone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Epidermal Growth Factor-Urogastrone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Epidermal Growth Factor-Urogastrone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Epidermal Growth Factor-Urogastrone supplier is an individual or a company that provides Epidermal Growth Factor-Urogastrone active pharmaceutical ingredient (API) or Epidermal Growth Factor-Urogastrone finished formulations upon request. The Epidermal Growth Factor-Urogastrone suppliers may include Epidermal Growth Factor-Urogastrone API manufacturers, exporters, distributors and traders.
click here to find a list of Epidermal Growth Factor-Urogastrone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Epidermal Growth Factor-Urogastrone DMF (Drug Master File) is a document detailing the whole manufacturing process of Epidermal Growth Factor-Urogastrone active pharmaceutical ingredient (API) in detail. Different forms of Epidermal Growth Factor-Urogastrone DMFs exist exist since differing nations have different regulations, such as Epidermal Growth Factor-Urogastrone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Epidermal Growth Factor-Urogastrone DMF submitted to regulatory agencies in the US is known as a USDMF. Epidermal Growth Factor-Urogastrone USDMF includes data on Epidermal Growth Factor-Urogastrone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Epidermal Growth Factor-Urogastrone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Epidermal Growth Factor-Urogastrone suppliers with USDMF on PharmaCompass.
Epidermal Growth Factor-Urogastrone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Epidermal Growth Factor-Urogastrone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Epidermal Growth Factor-Urogastrone GMP manufacturer or Epidermal Growth Factor-Urogastrone GMP API supplier for your needs.
A Epidermal Growth Factor-Urogastrone CoA (Certificate of Analysis) is a formal document that attests to Epidermal Growth Factor-Urogastrone's compliance with Epidermal Growth Factor-Urogastrone specifications and serves as a tool for batch-level quality control.
Epidermal Growth Factor-Urogastrone CoA mostly includes findings from lab analyses of a specific batch. For each Epidermal Growth Factor-Urogastrone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Epidermal Growth Factor-Urogastrone may be tested according to a variety of international standards, such as European Pharmacopoeia (Epidermal Growth Factor-Urogastrone EP), Epidermal Growth Factor-Urogastrone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Epidermal Growth Factor-Urogastrone USP).